247 related articles for article (PubMed ID: 24064721)
1. Signaling cascades of Pasteurella multocida toxin in immune evasion.
Kubatzky KF; Kloos B; Hildebrand D
Toxins (Basel); 2013 Sep; 5(9):1664-81. PubMed ID: 24064721
[TBL] [Abstract][Full Text] [Related]
2. Noncanonical G-protein-dependent modulation of osteoclast differentiation and bone resorption mediated by Pasteurella multocida toxin.
Strack J; Heni H; Gilsbach R; Hein L; Aktories K; Orth JH
mBio; 2014 Nov; 5(6):e02190. PubMed ID: 25389180
[TBL] [Abstract][Full Text] [Related]
3. Pasteurella multocida and immune cells.
Kubatzky KF
Curr Top Microbiol Immunol; 2012; 361():53-72. PubMed ID: 22427181
[TBL] [Abstract][Full Text] [Related]
4. Pasteurella multocida toxin - lessons learned from a mitogenic toxin.
Kubatzky KF
Front Immunol; 2022; 13():1058905. PubMed ID: 36591313
[TBL] [Abstract][Full Text] [Related]
5. Pasteurella multocida toxin prevents osteoblast differentiation by transactivation of the MAP-kinase cascade via the Gα(q/11)--p63RhoGEF--RhoA axis.
Siegert P; Schmidt G; Papatheodorou P; Wieland T; Aktories K; Orth JH
PLoS Pathog; 2013; 9(5):e1003385. PubMed ID: 23696743
[TBL] [Abstract][Full Text] [Related]
6. Vaccine potential of an attenuated Pasteurella multocida that expresses only the N-terminal truncated fragment of P. multocida toxin in pigs.
Kim T; Son C; Lee J; Kim K
Can J Vet Res; 2012 Jan; 76(1):69-71. PubMed ID: 22754098
[TBL] [Abstract][Full Text] [Related]
7. Pasteurella multocida toxin- induced osteoclastogenesis requires mTOR activation.
Kloos B; Chakraborty S; Lindner SG; Noack K; Harre U; Schett G; Krämer OH; Kubatzky KF
Cell Commun Signal; 2015 Sep; 13():40. PubMed ID: 26369790
[TBL] [Abstract][Full Text] [Related]
8.
Chakraborty S; Kloos B; Harre U; Schett G; Kubatzky KF
Front Immunol; 2017; 8():185. PubMed ID: 28289415
[TBL] [Abstract][Full Text] [Related]
9. The pasteurella multocida toxin interacts with signalling pathways to perturb cell growth and differentiation.
Lax AJ; Pullinger GD; Baldwin MR; Harmey D; Grigoriadis AE; Lakey JH
Int J Med Microbiol; 2004 Apr; 293(7-8):505-12. PubMed ID: 15149025
[TBL] [Abstract][Full Text] [Related]
10. Antigenicity of partial fragments of recombinant Pasteurella multocida toxin.
Lee J; Woo HJ
J Microbiol Biotechnol; 2010 Dec; 20(12):1756-63. PubMed ID: 21193834
[TBL] [Abstract][Full Text] [Related]
11. Protective potential of an attenuated Pasteurella multocida, which expresses only the N-terminal truncated fragment of P. multocida toxin.
Seo J; Lee S; Pyo H; Lee J; Kim T
Can J Vet Res; 2010 Jan; 74(1):25-9. PubMed ID: 20357954
[TBL] [Abstract][Full Text] [Related]
12. Cross-protection of recombinant Pasteurella multocida toxin proteins against atrophic rhinitis in mice.
Wu MC; Lo YT; Wu HC; Wang HY; Chu CY
Res Vet Sci; 2021 Jul; 137():138-143. PubMed ID: 33975192
[TBL] [Abstract][Full Text] [Related]
13. Development of a genetically modified nontoxigenic Pasteurella multocida toxin as a candidate for use in vaccines against progressive atrophic rhinitis in pigs.
To H; Someno S; Nagai S
Am J Vet Res; 2005 Jan; 66(1):113-8. PubMed ID: 15691045
[TBL] [Abstract][Full Text] [Related]
14. Pasteurella multocida toxin-stimulated osteoclast differentiation is B cell dependent.
Hildebrand D; Heeg K; Kubatzky KF
Infect Immun; 2011 Jan; 79(1):220-8. PubMed ID: 20956572
[TBL] [Abstract][Full Text] [Related]
15. Influence of Pasteurella multocida Toxin on the differentiation of dendritic cells into osteoclasts.
Chakraborty S; Kloos B; Roetz N; Schmidt S; Eigenbrod T; Kamitani S; Kubatzky KF
Immunobiology; 2018 Jan; 223(1):142-150. PubMed ID: 29030011
[TBL] [Abstract][Full Text] [Related]
16. Expression of a truncated Pasteurella multocida toxin antigen in Bordetella bronchiseptica.
Rajeev S; Nair RV; Kania SA; Bemis DA
Vet Microbiol; 2003 Jul; 94(4):313-23. PubMed ID: 12829385
[TBL] [Abstract][Full Text] [Related]
17. Effects of Pasteurella multocida toxin on porcine bone marrow cell differentiation into osteoclasts and osteoblasts.
Gwaltney SM; Galvin RJ; Register KB; Rimler RB; Ackermann MR
Vet Pathol; 1997 Sep; 34(5):421-30. PubMed ID: 9381653
[TBL] [Abstract][Full Text] [Related]
18. Detection of stable epitopes on formaldehyde-detoxified Pasteurella multocida toxin by monoclonal antibodies.
Foged NT
Vaccine; 1991 Nov; 9(11):817-24. PubMed ID: 1722064
[TBL] [Abstract][Full Text] [Related]
19. Immunological roles of Pasteurella multocida toxin (PMT) using a PMT mutant strain.
Kim TJ; Toan NT; Jang EJ; Jung BG; Lee JI; Lee BJ
J Microbiol; 2007 Aug; 45(4):364-6. PubMed ID: 17846592
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and efficacy of three recombinant subunit Pasteurella multocida toxin vaccines against progressive atrophic rhinitis in pigs.
Liao CM; Huang C; Hsuan SL; Chen ZW; Lee WC; Liu CI; Winton JR; Chien MS
Vaccine; 2006 Jan; 24(1):27-35. PubMed ID: 16122849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
